Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SURF-201 eye drop in cataract surgery patients to assess efficacy in reducing post-surgical ocular inflammation and pain; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SURF-201

Snippet

Sponsor: Surface Ophthalmics, Inc. | Conditions: Post-surgical Ocular Inflammation, Post-surgical Ocular Pain | Phase 2 | Status: COMPLETED | Results posted: 2023-10-18